TD has acquired Cowen Inc. Please bookmark TD Securities for further updates.

$964 Million

Horizon Therapeutics plc

Follow-on Offering

Financial Advisor, August 2020

Horizon Therapeutics plc

Horizon is focused on researching, developing and commercializing medicines that address critical needs for people impacted by rare and rheumatic diseases. Our pipeline is purposeful: we apply scientific expertise and courage to bring clinically meaningful therapies to patients. We believe science and compassion must work together to transform lives.